| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Medical Officer | Chief Medical Officer
1 company
Golden Lee Scott is an EVP &Chief Medical Officer at PTC Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $5.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | PTCT Ptc Therapeutics, Inc. | EVP &Chief Medical Officer | Sell | 829 | $67.99 | $56,363.71 | -1.0% | - | - | |
| Jan 8, 2026 | PTCT Ptc Therapeutics, Inc. | EVP &Chief Medical Officer | Sell | 866 | $76.45 | $66,205.70 | -0.9% | -7.3% | - | |
| Jan 7, 2026 | PTCT Ptc Therapeutics, Inc. | EVP &Chief Medical Officer | Sell | 1,982 | $77.12 | $152,855.16 | -1.0% | -9.9% | - | |
| Apr 2, 2025 | PTCT Ptc Therapeutics, Inc. | EVP &Chief Medical Officer | Sell | 897 | $46.95 | $42,114.15 | -1.2% | +0.5% | +40.1% | |
| Feb 20, 2025 | PTCT Ptc Therapeutics, Inc. | EVP &Chief Medical Officer | Sell | 1,757 | $50.11 | $88,045.61 | -1.1% | -8.3% | +40.3% | |
| Jan 8, 2025 | PTCT Ptc Therapeutics, Inc. | EVP &Chief Medical Officer | Sell | 2,008 | $44.84 | $90,036.40 | -1.3% | -11.7% | +70.6% | |
| May 7, 2024 | PTCT Ptc Therapeutics, Inc. | EVP &Chief Medical Officer | Sell | 175 | $32.82 | $5,743.50 | -0.3% | -2.5% | +28.2% | |
| Apr 2, 2024 | PTCT Ptc Therapeutics, Inc. | EVP &Chief Medical Officer | Sell | 526 | $28.37 | $14,922.62 | -0.9% | +9.8% | +70.3% | |
| Jan 9, 2024 | PTCT Ptc Therapeutics, Inc. | Chief Medical Officer | Sell | 2,000 | $28.87 | $57,739.36 | -2.5% | -6.4% | +56.9% |